A new family of rigid C2-symmetric cleft molecules as potential medicinal chemistry scaffolds

11 July 2022, Version 2
This content is a preprint and has not undergone peer review at the time of posting.

Abstract

The discovery of new scaffolds that selectively interact with biomolecules is vital in the development of new medicinal and chemical biology tools, therapeutics and sensors. Their binding and specificity is reliant on several well established factors, but there has been an increasing emphasis on identifying scaffolds that possess intrinisic 3-dimensionality. Herein, we report the synthesis, photophysical and preliminary ds-DNA binding properties of a new series of 3-D C2-symmetric carbocyclic cleft scaffolds. Their synthesis is realised through a 4-step procedure with the structures of each molecule established through single crystal X-ray crystallography. Their interaction with ds-DNA is probed using UV-Vis titration of the racemic ligands with ct-DNA with the preliminary studies establishing that the mode-of-binding as intercalative, with Kb values between 1.28 x 106 to 2.32 x 105 M-1. This is further supported using computational DNA-docking studies that demonstrate that complementarity 3D shapes of these ligands is essential for B-DNA binding.

Keywords

Scaffold
Cleft molecule
DNA
Docking studies
C2-symmetric

Supplementary materials

Title
Description
Actions
Title
SI information
Description
Synthetic procedures, 1H and 13C NMR data, DNA binding studies data, X-ray crystallographic data, and details of docking studies.
Actions

Comments

Comments are not moderated before they are posted, but they can be removed by the site moderators if they are found to be in contravention of our Commenting Policy [opens in a new tab] - please read this policy before you post. Comments should be used for scholarly discussion of the content in question. You can find more information about how to use the commenting feature here [opens in a new tab] .
This site is protected by reCAPTCHA and the Google Privacy Policy [opens in a new tab] and Terms of Service [opens in a new tab] apply.